Instrument Business Outlook Volume 32 - Issue 21

16 Feb 2024

Categories:

Instrument Business Outlook

Table of Contents

New US Lab Construction Leads to Oversupply
- Commercial Developments
- New Labs for Lease Planned
  - New Lab Space Coming to San Francisco
  - Biotech Labs Set for Cambridge
  - Site Expansion Near San Diego
- New Lab Buildings Planned
  - Chinese Pharma Company to Expand
  - New Japanese Lab for Oil Processing
  - Biotech Labs Set for Virginia
  - Brown University Plans 300,000 Square Foot Building
  - New State Crime Lab Announced
Executive Briefing
- NanoString Files for Bankruptcy
- Bruker Makes Two Acquisitions
- Bio-Techne Lays Off Employees
Fourth Quarter Results: Bio-Techne, QIAGEN and Shimadzu
- Bio-Techne Records Pockets of Growth Despite Quarterly Decline
  - End-Markets
  - Regions
  - Divisions
  - Guidance
- QIAGEN Concludes 2023 with Mixed Results
  - Q4
  - FYE
- Shimadzu AMI Benefitting from Green Sector Demand
  - Product Lines
  - Regions
  - End-Markets
  - Guidance
Market Profile: Organ-on-a-Chip
- Leading Vendors
- Largest Markets
- Instrument Cost
Industry Watch
- Biopharma: Lab Transformation
- Biotech: IPO Rebound
- Government: Animal Testing Alternatives
Region Watch
- EU: Horizon Europe’s Budget Cut
- China: Solid-State Battery R&D
- UK: 2022’s Health Research Funding
News
- Life Science Consumables
  - Company Announcements
  - Gene-Based Analysis
  - Company Announcements
  - Product Introductions
  - Cell-Based Analysis
  - Company Announcements
  - Product Introductions
  - Protein-Based Analysis
  - Company Announcements
  - Product Introductions
- Sequencing
  - Company Announcements
  - Product Introductions
- Spectroscopy
  - Company Announcements
  - Product Introductions
  - Sale & Orders of Note
- Informatics
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
Bottom Line

Attachments

IBO 021524 Issue.pdf